{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:24:57Z","timestamp":1791923097243,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273152"],"award-info":[{"award-number":["82273152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072832"],"award-info":[{"award-number":["82072832"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073306"],"award-info":[{"award-number":["82073306"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Province Hospital (the First Affiliated Hospital of Nanjing Medical University) Clinical Capacity Enhancement Project","award":["JSPH-MA-2022\u20135"],"award-info":[{"award-number":["JSPH-MA-2022\u20135"]}]},{"name":"Jiangsu Province Capability Improvement Project through Science, Technology and Education","award":["ZDXK202219"],"award-info":[{"award-number":["ZDXK202219"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20241128"],"award-info":[{"award-number":["BK20241128"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06547-7","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T05:44:55Z","timestamp":1747892695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["SRSF1-mediated alternative splicing regulates bladder cancer progression and cisplatin sensitivity through HIF1A\/BNIP3\/mitophagy axis"],"prefix":"10.1186","volume":"23","author":[{"given":"Qikai","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyou","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntao","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingkai","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3589-2507","authenticated-orcid":false,"given":"Qiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"2024","key":"6547_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2022;74(2024):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"6547_CR2","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, et al. Bladder cancer: a review. JAMA. 2020;324:1980\u201391.","journal-title":"JAMA"},{"key":"6547_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1470-2045(23)00587-9","volume":"25","author":"C Pfister","year":"2024","unstructured":"Pfister C, Gravis G, Flechon A, et al. Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study. Lancet Oncol. 2024;25:255\u201364.","journal-title":"Lancet Oncol"},{"key":"6547_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.eururo.2020.08.024","volume":"79","author":"C Pfister","year":"2021","unstructured":"Pfister C, Gravis G, Flechon A, et al. Randomized phase III trial of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin, or gemcitabine and cisplatin as perioperative chemotherapy for patients with muscle-invasive bladder cancer. Analysis of the GETUG\/AFU V05 VESPER trial secondary endpoints: chemotherapy toxicity and pathological responses. Eur Urol. 2021;79:214\u201321.","journal-title":"Eur Urol"},{"key":"6547_CR5","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.7150\/thno.83920","volume":"13","author":"M Liu","year":"2023","unstructured":"Liu M, Zhang S, Zhou H, et al. The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer. Theranostics. 2023;13:2616\u201331.","journal-title":"Theranostics"},{"key":"6547_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nrc.2016.51","volume":"16","author":"H Dvinge","year":"2016","unstructured":"Dvinge H, Kim E, Abdel-Wahab O, et al. RNA splicing factors as oncoproteins and tumour suppressors. Nat Rev Cancer. 2016;16:413\u201330.","journal-title":"Nat Rev Cancer"},{"key":"6547_CR7","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.7150\/ijbs.46751","volume":"16","author":"X Zheng","year":"2020","unstructured":"Zheng X, Peng Q, Wang L, et al. Serine\/arginine-rich splicing factors: the bridge linking alternative splicing and cancer. Int J Biol Sci. 2020;16:2442\u201353.","journal-title":"Int J Biol Sci"},{"key":"6547_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cytogfr.2020.10.008","volume":"57","author":"S Paz","year":"2021","unstructured":"Paz S, Ritchie A, Mauer C, et al. The RNA binding protein SRSF1 is a master switch of gene expression and regulation in the immune system. Cytokine Growth Factor Rev. 2021;57:19\u201326.","journal-title":"Cytokine Growth Factor Rev"},{"key":"6547_CR9","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1158\/1541-7786.MCR-14-0131","volume":"12","author":"S Das","year":"2014","unstructured":"Das S, Krainer AR. Emerging functions of SRSF1, splicing factor and oncoprotein, RNA metabolism and cancer. Mol Cancer Res. 2014;12:1195\u2013204.","journal-title":"Mol Cancer Res"},{"key":"6547_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.celrep.2011.12.001","volume":"1","author":"S Das","year":"2012","unstructured":"Das S, Anczukow O, Akerman M, et al. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC. Cell Rep. 2012;1:110\u20137.","journal-title":"Cell Rep"},{"key":"6547_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41467-023-35932-3","volume":"14","author":"W Arif","year":"2023","unstructured":"Arif W, Mathur B, Saikali MF, et al. Splicing factor SRSF1 deficiency in the liver triggers NASH-like pathology and cell death. Nat Commun. 2023;14:551.","journal-title":"Nat Commun"},{"key":"6547_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13046-021-01931-9","volume":"40","author":"J Zhao","year":"2021","unstructured":"Zhao J, Jiang Y, Zhang H, et al. The SRSF1\/circATP5B\/miR-185-5p\/HOXB5 feedback loop regulates the proliferation of glioma stem cells via the IL6-mediated JAK2\/STAT3 signaling pathway. J Exp Clin Cancer Res. 2021;40:134.","journal-title":"J Exp Clin Cancer Res"},{"key":"6547_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13046-021-01978-8","volume":"40","author":"JX Du","year":"2021","unstructured":"Du JX, Luo YH, Zhang SJ, et al. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1. J Exp Clin Cancer Res. 2021;40:171.","journal-title":"J Exp Clin Cancer Res"},{"key":"6547_CR14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1172\/JCI120279","volume":"129","author":"X Zhou","year":"2019","unstructured":"Zhou X, Wang R, Li X, et al. Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B. J Clin Invest. 2019;129:676\u201393.","journal-title":"J Clin Invest"},{"key":"6547_CR15","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1038\/onc.2012.306","volume":"32","author":"L Adesso","year":"2013","unstructured":"Adesso L, Calabretta S, Barbagallo F, et al. Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2\/eIF4E pathway. Oncogene. 2013;32:2848\u201357.","journal-title":"Oncogene"},{"key":"6547_CR16","doi-asserted-by":"publisher","first-page":"e13327","DOI":"10.1111\/cpr.13327","volume":"55","author":"C Song","year":"2022","unstructured":"Song C, Pan S, Zhang J, et al. Mitophagy: a novel perspective for insighting into cancer and cancer treatment. Cell Prolif. 2022;55:e13327.","journal-title":"Cell Prolif"},{"key":"6547_CR17","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1080\/15548627.2021.1975914","volume":"18","author":"T Zhang","year":"2022","unstructured":"Zhang T, Liu Q, Gao W, et al. The multifaceted regulation of mitophagy by endogenous metabolites. Autophagy. 2022;18:1216\u201339.","journal-title":"Autophagy"},{"key":"6547_CR18","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1080\/15548627.2020.1802089","volume":"17","author":"X Wu","year":"2021","unstructured":"Wu X, Zheng Y, Liu M, et al. BNIP3L\/NIX degradation leads to mitophagy deficiency in ischemic brains. Autophagy. 2021;17:1934\u201346.","journal-title":"Autophagy"},{"key":"6547_CR19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s12094-018-1958-5","volume":"21","author":"L Hui","year":"2019","unstructured":"Hui L, Wu H, Wang TW, et al. Hydrogen peroxide-induced mitophagy contributes to laryngeal cancer cells survival via the upregulation of FUNDC1. Clin Transl Oncol. 2019;21:596\u2013606.","journal-title":"Clin Transl Oncol"},{"key":"6547_CR20","doi-asserted-by":"publisher","first-page":"20988","DOI":"10.18632\/oncotarget.15470","volume":"8","author":"C Zhao","year":"2017","unstructured":"Zhao C, Chen Z, Qi J, et al. Drp1-dependent mitophagy protects against cisplatin-induced apoptosis of renal tubular epithelial cells by improving mitochondrial function. Oncotarget. 2017;8:20988\u20131000.","journal-title":"Oncotarget"},{"key":"6547_CR21","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.7150\/jca.20814","volume":"8","author":"L Chen","year":"2017","unstructured":"Chen L, Yao Y, Sun L, et al. Galectin-1 promotes tumor progression via NF-kappaB signaling pathway in epithelial ovarian cancer. J Cancer. 2017;8:3733\u201341.","journal-title":"J Cancer"},{"key":"6547_CR22","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41419-022-04741-9","volume":"13","author":"C Vianello","year":"2022","unstructured":"Vianello C, Cocetta V, Catanzaro D, et al. Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy. Cell Death Dis. 2022;13:398.","journal-title":"Cell Death Dis"},{"key":"6547_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.canlet.2016.11.018","volume":"388","author":"C Yan","year":"2017","unstructured":"Yan C, Luo L, Guo CY, et al. Doxorubicin-induced mitophagy contributes to drug resistance in cancer stem cells from HCT8 human colorectal cancer cells. Cancer Lett. 2017;388:34\u201342.","journal-title":"Cancer Lett"},{"key":"6547_CR24","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/cam4.1112","volume":"6","author":"H Hou","year":"2017","unstructured":"Hou H, Er P, Cheng J, et al. High expression of FUNDC1 predicts poor prognostic outcomes and is a promising target to improve chemoradiotherapy effects in patients with cervical cancer. Cancer Med. 2017;6:1871\u201381.","journal-title":"Cancer Med"},{"key":"6547_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1515\/hsz-2018-0210","volume":"400","author":"A Abdrakhmanov","year":"2019","unstructured":"Abdrakhmanov A, Kulikov AV, Luchkina EA, et al. Involvement of mitophagy in cisplatin-induced cell death regulation. Biol Chem. 2019;400:161\u201370.","journal-title":"Biol Chem"},{"key":"6547_CR26","doi-asserted-by":"crossref","unstructured":"Kool R, Dragomir A, Kulkarni GS, et al. Benefit of neoadjuvant cisplatin-based chemotherapy for invasive bladder cancer patients treated with radiation-based therapy in a real-world setting: an inverse probability treatment weighted analysis. Eur Urol Oncol. 2024.","DOI":"10.1016\/j.euo.2024.01.014"},{"key":"6547_CR27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.eururo.2021.10.035","volume":"81","author":"G Sjodahl","year":"2022","unstructured":"Sjodahl G, Abrahamsson J, Holmsten K, et al. Different responses to neoadjuvant chemotherapy in urothelial carcinoma molecular subtypes. Eur Urol. 2022;81:523\u201332.","journal-title":"Eur Urol"},{"key":"6547_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0092-8674(90)90237-9","volume":"62","author":"AR Krainer","year":"1990","unstructured":"Krainer AR, Conway GC, Kozak D. The essential pre-mRNA splicing factor SF2 influences 5\u2032 splice site selection by activating proximal sites. Cell. 1990;62:35\u201342.","journal-title":"Cell"},{"key":"6547_CR29","doi-asserted-by":"crossref","unstructured":"Jin X. Regulatory network of serine\/arginine-rich (SR) proteins: the molecular mechanism and physiological function in plants. Int J Mol Sci. 2022;23.","DOI":"10.3390\/ijms231710147"},{"key":"6547_CR30","doi-asserted-by":"publisher","first-page":"113816","DOI":"10.1016\/j.celrep.2024.113816","volume":"43","author":"HM Scott","year":"2024","unstructured":"Scott HM, Smith MH, Coleman AK, et al. Serine\/arginine-rich splicing factor 7 promotes the type I interferon response by activating Irf7 transcription. Cell Rep. 2024;43:113816.","journal-title":"Cell Rep"},{"key":"6547_CR31","doi-asserted-by":"crossref","unstructured":"Leclair NK, Brugiolo M, Urbanski L, et al. Poison exon splicing regulates a coordinated network of sr protein expression during differentiation and tumorigenesis. Mol Cell. 2020;80:648\u2013665 e649.","DOI":"10.1016\/j.molcel.2020.10.019"},{"key":"6547_CR32","doi-asserted-by":"publisher","first-page":"217088","DOI":"10.1016\/j.canlet.2024.217088","volume":"598","author":"Y Wu","year":"2024","unstructured":"Wu Y, Wang J, Zhao J, et al. LTR retrotransposon-derived LncRNA LINC01446 promotes hepatocellular carcinoma progression and angiogenesis by regulating the SRPK2\/SRSF1\/VEGF axis. Cancer Lett. 2024;598:217088.","journal-title":"Cancer Lett"},{"key":"6547_CR33","doi-asserted-by":"publisher","first-page":"109861","DOI":"10.1016\/j.isci.2024.109861","volume":"27","author":"S Mao","year":"2024","unstructured":"Mao S, Wu D, Cheng X, et al. Circ_0007432 promotes non-small cell lung cancer progression and macrophage M2 polarization through SRSF1\/KLF12 axis. iScience. 2024;27:109861.","journal-title":"iScience"},{"key":"6547_CR34","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1186\/s12885-024-12346-y","volume":"24","author":"S Li","year":"2024","unstructured":"Li S, Huang X, Zheng S, et al. High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms. BMC Cancer. 2024;24:580.","journal-title":"BMC Cancer"},{"key":"6547_CR35","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41419-022-04791-z","volume":"13","author":"TI Hwang","year":"2022","unstructured":"Hwang TI, Chen PC, Tsai TF, et al. Hsa-miR-30a-3p overcomes the acquired protective autophagy of bladder cancer in chemotherapy and suppresses tumor growth and muscle invasion. Cell Death Dis. 2022;13:390.","journal-title":"Cell Death Dis"},{"key":"6547_CR36","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.juro.2015.10.128","volume":"195","author":"YC Lin","year":"2016","unstructured":"Lin YC, Lin JF, Wen SI, et al. Inhibition of high basal level of autophagy induces apoptosis in human bladder cancer cells. J Urol. 2016;195:1126\u201335.","journal-title":"J Urol"},{"key":"6547_CR37","doi-asserted-by":"crossref","unstructured":"Mao X, Nanzhang, Xiao J, et al. Hypoxia-induced autophagy enhances cisplatin resistance in human bladder cancer cells by targeting hypoxia-inducible factor-1alpha. J Immunol Res. 2021;2021:8887437.","DOI":"10.1155\/2021\/8887437"},{"key":"6547_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.23736\/S0031-0808.16.03182-7","volume":"59","author":"Z Fan","year":"2017","unstructured":"Fan Z, Huangfu X, Liu Z. Effect of autophagy on cisplatin-induced bladder cancer cell apoptosis. Panminerva Med. 2017;59:1\u20138.","journal-title":"Panminerva Med"},{"key":"6547_CR39","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.7150\/ijbs.86719","volume":"20","author":"H Yu","year":"2024","unstructured":"Yu H, Zhuang J, Zhou Z, et al. METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway. Int J Biol Sci. 2024;20:1471\u201391.","journal-title":"Int J Biol Sci"},{"key":"6547_CR40","doi-asserted-by":"publisher","first-page":"114398","DOI":"10.1016\/j.biopha.2023.114398","volume":"160","author":"S Mukherjee","year":"2023","unstructured":"Mukherjee S, Bhatti GK, Chhabra R, et al. Targeting mitochondria as a potential therapeutic strategy against chemoresistance in cancer. Biomed Pharmacother. 2023;160:114398.","journal-title":"Biomed Pharmacother"},{"key":"6547_CR41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.biopha.2018.06.128","volume":"106","author":"L Liu","year":"2018","unstructured":"Liu L, Zuo Z, Lu S, et al. Silencing of PINK1 represses cell growth, migration and induces apoptosis of lung cancer cells. Biomed Pharmacother. 2018;106:333\u201341.","journal-title":"Biomed Pharmacother"},{"key":"6547_CR42","doi-asserted-by":"crossref","unstructured":"Song W, Li Z, Yang K, et al. Antisense lncRNA-RP11-498C9.13 promotes bladder cancer progression by enhancing reactive oxygen species-induced mitophagy. J Gene Med. 2023;25: e3527.","DOI":"10.1002\/jgm.3527"},{"key":"6547_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-023-02638-9","volume":"42","author":"Y Sun","year":"2023","unstructured":"Sun Y, Shen W, Hu S, et al. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy. J Exp Clin Cancer Res. 2023;42:65.","journal-title":"J Exp Clin Cancer Res"},{"key":"6547_CR44","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.7150\/ijbs.80775","volume":"19","author":"Q Lin","year":"2023","unstructured":"Lin Q, Li S, Jin H, et al. Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS\/HO-1\/GPX4 axis. Int J Biol Sci. 2023;19:1192\u2013210.","journal-title":"Int J Biol Sci"},{"key":"6547_CR45","doi-asserted-by":"publisher","first-page":"21156","DOI":"10.1021\/acsnano.4c04024","volume":"18","author":"H Lu","year":"2024","unstructured":"Lu H, Tong W, Jiang M, et al. Mitochondria-targeted multifunctional nanoprodrugs by inhibiting metabolic reprogramming for combating cisplatin-resistant lung cancer. ACS Nano. 2024;18:21156\u201370.","journal-title":"ACS Nano"},{"key":"6547_CR46","doi-asserted-by":"publisher","first-page":"113385","DOI":"10.1016\/j.celrep.2023.113385","volume":"42","author":"WJ Li","year":"2023","unstructured":"Li WJ, Huang Y, Lin YA, et al. Targeting PRMT1-mediated SRSF1 methylation to suppress oncogenic exon inclusion events and breast tumorigenesis. Cell Rep. 2023;42:113385.","journal-title":"Cell Rep"},{"key":"6547_CR47","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1158\/2159-8290.CD-22-1013","volume":"13","author":"L Wan","year":"2023","unstructured":"Wan L, Lin KT, Rahman MA, et al. Splicing factor SRSF1 promotes pancreatitis and KRASG12D-mediated pancreatic cancer. Cancer Discov. 2023;13:1678\u201395.","journal-title":"Cancer Discov"},{"key":"6547_CR48","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1158\/1541-7786.MCR-11-0061","volume":"9","author":"JC Shultz","year":"2011","unstructured":"Shultz JC, Goehe RW, Murudkar CS, et al. SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells. Mol Cancer Res. 2011;9:889\u2013900.","journal-title":"Mol Cancer Res"},{"key":"6547_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ebiom.2018.11.007","volume":"38","author":"J Sheng","year":"2018","unstructured":"Sheng J, Zhao Q, Zhao J, et al. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance. EBioMedicine. 2018;38:113\u201326.","journal-title":"EBioMedicine"},{"key":"6547_CR50","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1093\/nar\/gkv223","volume":"43","author":"DF Comiskey Jr","year":"2015","unstructured":"Comiskey DF Jr, Jacob AG, Singh RK, et al. Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage. Nucleic Acids Res. 2015;43:4202\u201318.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06547-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06547-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06547-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:36:06Z","timestamp":1757172966000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06547-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6547"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06547-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of The First Affiliated Hospital of Nanjing Medical University approved all human-associated tissues used in this research. The informed consent has been signed by all patients before their tissues were acquired.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"571"}}